BS EN ISO 11607-2-2020 + A1-2023 PDF

Full title and description

STB BS EN ISO 11607-2:2020 + A1:2023 — Packaging for terminally sterilized medical devices — Part 2: Validation requirements for forming, sealing and assembly processes, with Amendment 1 (Application of risk management). This publication is the British/European adoption of ISO 11607-2 (Part 2) together with the A1 amendment that integrates explicit risk-management requirements into process validation for sterile barrier systems and packaging processes.

Abstract

Specifies requirements for development, qualification and ongoing control of forming, sealing and assembly processes used to produce sterile barrier systems and packaging systems for terminally sterilized medical devices. The A1:2023 amendment extends the Part 2 requirements by requiring systematic application of risk management across design, process development, validation, production control, change management and revalidation activities.

General information

• Status: Current (EN/BS adoption of ISO 11607-2:2019 with Amendment A1:2023).
• Publication date: EN/BS edition published as EN ISO 11607-2:2020 (registered 1 February 2020); Amendment A1 published in 2023 (ISO publication: September 2023; BSI adoption/publication: 31 October 2023 / national registrations early November 2023).
• Publisher: BSI (as BS EN ISO adoption) / based on ISO technical work (ISO/TC 198).
• ICS / categories: 11.080.30 — Sterilized packaging; Medical device packaging; Sterilization and hygiene.
• Edition / version: EN ISO 11607-2:2020 (adoption of ISO 11607-2:2019, Edition 2) + Amendment A1:2023 (application of risk management).
• Number of pages: ISO main Part 2 document: 13 pages; ISO Amendment A1: 6 pages; consolidated national publications may vary (combined ≈ 19 pages; some consolidated editions list up to ~24 pages depending on national formatting).

Scope

This standard defines requirements for the development, validation and control of manufacturing processes that form, seal and assemble sterile barrier systems and packaging systems intended to maintain sterility of medical devices until point of use after terminal sterilization. It applies to industry and health-care facilities where terminal sterilization in the package is performed. It does not cover all requirements for aseptically manufactured devices or additional requirements that may be necessary for combined drug/device products. The 2023 amendment (A1) requires the documented application of risk management principles to process validation, production control, change control and revalidation.

Key topics and requirements

• Process development and documented justification of forming, sealing and assembly methods for sterile barrier systems.
• Installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ) of equipment and processes used for forming, sealing and assembly.
• Defined acceptance criteria, sampling plans and test methods for seals, package integrity and functional performance.
• Control of process parameters, environmental conditions and operator competencies that influence sterile barrier integrity.
• Traceable documentation: protocols, validation reports, records for routine production and nonconforming products.
• Change control, revalidation triggers and periodic review of process performance.
• Application of risk management (A1): identify hazards, estimate and evaluate risks, apply risk controls and document residual risk in accordance with a risk-management process (aligned with ISO 14971 principles).
• Requirements for sampling, statistical analysis and monitoring to demonstrate ongoing process capability and stability.
• Integration with device-level sterile-processing and sterilization validation (coordination with sterilization standards as applicable).

Typical use and users

Used by medical device manufacturers, packaging engineers, process validation specialists, quality assurance and regulatory teams, contract packagers, sterilization engineers, hospital sterile-services departments and conformity assessment bodies. Commonly referenced during design transfer, validation of packaging lines, regulatory submissions, supplier qualification and audits.

Related standards

ISO 11607-1 (requirements for materials, sterile barrier systems and packaging systems), ISO 14971 (risk management for medical devices), ISO 13485 (quality management systems for medical devices), relevant sterilization standards (ISO 11135, ISO 11137, EN 556), national/adopted EN standards for packaging materials (EN 868 series), and other guidance on validation, sealing integrity and biocompatibility as applicable.

Keywords

sterile barrier system; packaging validation; forming; sealing; assembly processes; process validation; risk management; medical device packaging; terminal sterilization; seal integrity; IQ/OQ/PQ; change control.

FAQ

Q: What is this standard?

A: EN/BS adoption of ISO 11607-2: Part 2 sets out validation requirements for forming, sealing and assembly processes used to produce sterile barrier systems for terminally sterilized medical devices. The A1:2023 amendment adds explicit requirements for applying risk management to those activities.

Q: What does it cover?

A: It covers process development, qualification (IQ/OQ/PQ), acceptance criteria, sampling and testing, production control, documentation, change control and revalidation for packaging processes that maintain device sterility until use. Amendment A1 extends these requirements by mandating the application of a documented risk-management process across these lifecycle activities.

Q: Who typically uses it?

A: Packaging and process validation engineers, QA/RA teams in medical device manufacturers, contract packagers, sterile services departments, conformity assessment bodies and auditors use this standard to design, validate and control packaging processes and to demonstrate regulatory compliance.

Q: Is it current or superseded?

A: The Part 2 document (ISO 11607-2:2019 adopted as EN ISO 11607-2:2020) is current. Amendment A1 (Application of risk management) was published in 2023 and has been adopted into national/European/BS documents (BS EN ISO 11607-2:2020 + A1:2023). Users should refer to their national standards body for the exact published/adoption date and consolidated text for their jurisdiction.

Q: Is it part of a series?

A: Yes. ISO 11607 is a two-part series: Part 1 (materials, sterile barrier systems and packaging systems) and Part 2 (validation requirements for forming, sealing and assembly processes). Both parts, plus any amendments, should be considered together when demonstrating packaging and sterilization compliance.

Q: What are the key keywords?

A: sterile barrier system; packaging validation; forming; sealing; assembly; process qualification; risk management; terminal sterilization; seal integrity; ISO 11607.